scholarly journals Pneumatosis Cystoides Intestinalis after Cetuximab Chemotherapy for Squamous Cell Carcinoma of Parotid Gland

2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Christos Petrides ◽  
Neofytou Kyriakos ◽  
Ioannou Andreas ◽  
Parpounas Konstantinos ◽  
Georgiou Chrysanthos ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Bowel Wall ◽  
Gastrointestinal Disease ◽  
Radiographic Finding ◽  
Pneumatosis Intestinalis ◽  
Ct Scans ◽  
Abdominal Radiographs ◽  
Cetuximab Therapy

Pneumatosis intestinalis, defined as gas in the bowel wall, is often first identified on abdominal radiographs or computed tomography (CT) scans. It is a radiographic finding and not a diagnosis, as the etiology varies from benign conditions to fulminant gastrointestinal disease. We report here a case of pneumatosis intestinalis associated with cetuximab therapy for squamous cell carcinoma of head and neck. The patient underwent laparotomy based on the CT scan and the result was pneumatosis intestinalis without any signs of necrotizing enterocolitis.

Usability of image fusion: optimal opacification of vessels and squamous cell carcinoma in CT scans

2006 ◽  
Vol 123 (4) ◽  
pp. 144-147
Author(s):  
M. Wiltgen ◽  
A. Holzinger ◽  
R. Groell ◽  
G. Wolf ◽  
W. Habermann
Keyword(s):  
Squamous Cell Carcinoma ◽  
Image Fusion ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Ct Scans

scholarly journals Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma

2021 ◽  
Vol 3 (3) ◽  
pp. e200131
Author(s):  
Derek Hsu ◽  
Tanya J. Rath ◽  
Barton F. Branstetter ◽  
Yoshimi Anzai ◽  
C. Douglas Phillips ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Interrater Reliability ◽  
Neck Squamous Cell Carcinoma ◽  
Ct Scans ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct

scholarly journals Dynamics of changes in type 1 and 2 insulinlike growth factors in the blood of patients with oral squamous cell cancer after targeted therapy with cetuximab

2021 ◽  
Vol 11 (1) ◽  
pp. 29-36
Author(s):  
A.  A. Lyanova ◽  
L.  Yu. Vladimirova ◽  
E.  M. Frantsiyants ◽  
I.  V. Neskubina ◽  
M.  A. Engibaryan ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Growth Factors ◽  
Targeted Therapy ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Blood Levels ◽  
Therapy Effect ◽  
Cetuximab Therapy ◽  
Carcinoma Of The Tongue

Objective. Studying the blood levels of type 1 and 2 insulin-like growth factors in patients with squamous cell carcinoma of the tongue and mouth floor mucosa depending on the therapy effect.Materials and Methods. The study included data from 30 patients with squamous cell carcinoma of the tongue and mouth floor mucosa T3–4N0–1M0 who received chemotherapy cycles together with targeted therapy with cetuximab. Twenty non-cancer donors were examined as well. Depending on the therapy effect, patients were divided into two groups: sensitive and resistant ones.Results. Initial levels of IGF-1 and IGF-2 in the blood serum of patients prior to chemotherapy and targeted therapy with cetuximab were lower than the levels in donors by 53.5 % and 20.3 %, respectively. After chemotherapy and cetuximab therapy, patients with sensitivity to the treatment showed normalization of IGF-1 and its significant increase compared to the initial levels — by 87 %. Levels of IGF-2 were not statistically significantly different from the initial levels and were 32.5 % lower than in donors. The IGF-1 / IGF-2 coefficient was 58 % higher than the initial value.Conclusions. Chemotherapy and cetuximab therapy normalized levels of IGF-1 in patients with sensitivity to the treatment which was demonstrated by an increase in IGF-1 up to the normal blood levels in effective treatment.

Deep Spread Patterns in CT Staging of T2–4 Squamous Cell Laryngeal Carcinoma

1988 ◽  
Vol 99 (5) ◽  
pp. 455-464 ◽  
Author(s):  
John H. Isaacs ◽  
Anthony A. Mancuso ◽  
William M. Mendenhall ◽  
James T. Parsons
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Primary Site ◽  
Ct Scans ◽  
Recurrent Cancer ◽  
Significant Complication ◽  
Local Recurrences ◽  
Carcinoma Of The Larynx ◽  
Favorable Group

In addition to clinical examination and less sophisticated radiographic techniques, high-resolution computerized tomography (CT) can help to stage squamous cell carcinoma of the larynx. This study was undertaken to identify findings on CT scans that might predict the likelihood of radiation therapy (RT) alone, controlling the primary site disease without significant irradiation-related complications. Of 30 patients with T2–4 cancers of the larynx, 13 were classified as favorable and 17 were classified as unfavorable candidates for RT based on the CT criteria of transglottic spread, more than 25% pre-epiglottic space involvement, extensive paralaryngeal space spread, or cartilage involvement. Seven of 17 (41%) unfavorable patients had local recurrences, two are alive with cancer, three patients are dead of disease (DOD), and five had significant complication, but there was no evidence of recurrent cancer. In the favorable group, there were two local recurrences (15%), one distant metastasis, one patient is DOD, and one had a significant complication, but no recurrent cancer. These data may be used to more adequately select and inform patients with T2–4 squamous cell carcinoma of the larynx before RT.

Cetuximab Therapy for Head and Neck Squamous Cell Carcinoma

2011 ◽  
Vol 144 (5) ◽  
pp. 676-684 ◽  
Author(s):  
Travis D. Reeves ◽  
Elizabeth G. Hill ◽  
Kent E. Armeson ◽  
M. Boyd Gillespie
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Cetuximab Therapy
Sign in / Sign up

Export Citation Format

Share Document